Listen in as Jonathan A. Bernstein, MD, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discuss how to manage the multidisciplinary care of patients with systemic mastocytosis (SM) from both the allergy/immunology and pharmacy perspective, including:

• Strategies to better identify patients presenting with features of SM to facilitate timely diagnosis
• Current guideline-recommended treatment approaches
• Emerging data on new targeted agents for SM
• Pharmacist-led strategies to help patients achieve better outcomes (e.g., specialist referral, polypharmacy counseling, and anaphylaxis education)

Presenters
Jonathan A. Bernstein, MD
Professor of Medicine
Division of Rheumatology, Allergy and Immunology
Department of Internal Medicine
University of Cincinnati College of Medicine
Partner Advanced Allergy Services, LLC
Partner Bernstein Clinical Research Center, LLC
Cincinnati, Ohio

Ryan Haumschild, PharmD, MS, MBA, CPEL
Vice President of Pharmacy, Ambulatory
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia

Full link to program page:
https://bit.ly/3HcA8z2

In this podcast episode, Allison Butts, PharmD, BCOP, reviews how pharmacists can help in providing comprehensive patient-centric care for patients with HR+/HER2- MBC and preexisting comorbid conditions, including:

• Common comorbidities and complexities in managing patients with HR+/HER2- MBC
• Treatment landscape for patients with HR+/HER2- MBC
• Real-world studies in women with HR+/HER2- MBC
• Mitigation and management of drug interactions and multidisciplinary team coordination treatment selection
• Patient goals and coordinating with multidisciplinary team to maximize quality of life

Link to full program:
https://bit.ly/4jCQe38

In this episode, Alexa Basilio, PharmD, BCOP and Jessica Davis, PharmD, BCOP, CPP discuss immune-related adverse events and toxicities among patients using immune checkpoint inhibitors. This overview will include discussion about:

• How and when to monitor and treat mild vs severe immune-related toxicities
• The art of balancing and tapering low-dose and high-dose corticosteroids
• Differentiating between immune-related and chemotherapy- or targeted therapy–associated adverse events for optimal management approaches
• Involvement of multidisciplinary teams early during treatment to prevent immune-related adverse events
• Importance of educating patients, caregivers, and providers on immune-related toxicities

Presenters:

Alexa Basilio, PharmD, BCOP
University of Florida College of Pharmacy
Oncology Pharmacy Specialist
McKesson, The US Oncology Network
Tampa, Florida

Jessica Davis, PharmD, BCOP, CPP
Levine Cancer Institute
Clinical Pharmacist Coordinator, Adult Hematology/Oncology
Atrium Health Levine Center
Charlotte, North Carolina

Link to full program:
https://bit.ly/3We4HJy